The Gilbert Family Foundation’s (GFF) Gene Therapy Initiative is accepting proposals for high-impact research on gene therapy strategies aimed at addressing the loss of neurofibromin 1 (NF1) gene function in neurofibromatosis type 1 (NF1) patients.  This Request for Proposal (RFP) will focus on the development of therapeutic strategies, including drug delivery systems, designed to address the mutant NF1 allele or protect and/or enhance the functioning of the normal NF1 allele.

Proposals will be accepted for Team Science Awards defined as collaborative research amongst investigators with experience in gene-targeting strategies in or outside the NF1 field.  There will be a two-stage peer-reviewed application process:

  1. In the first stage, Letters of Intent (LOIs) are due by February 28, 2021.
  2. GFF will select LOIs to advance and notify applicants of their application status of April 1st, 2021.  For those applications selected to advance, full-length proposals will be due by May 31st, 2021.
Access Full RFP
Access the Application
View GFF’s Announcement